Urinary β2M excretion has also been used in the diagnosis of a variety of renal diseases that affect tubulo-interstitial function including tubule-interstitial nephritis with uveitis (182), hemoglobinopathies such as sickle cell disease (183, 184), as well as children who have received chemotherapy as part of their cancer treatment (185). Here, B2M is linked to kidney disorder.